These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6609283)

  • 1. Clinical significance of autorosette-forming cells in T-cell lymphoma.
    Tamura K; Aratake Y; Endo Y; Ohtaki S
    Leuk Res; 1984; 8(2):275-83. PubMed ID: 6609283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant lymphomas of follicular center cell origin in man. I. Immunologic studies.
    Leech JH; Glick AD; Waldron JA; Flexner JM; Horn RG; Collins RD
    J Natl Cancer Inst; 1975 Jan; 54(1):11-21. PubMed ID: 1089792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
    Knowles DM; Halper JP; Jakobiec FA
    Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further characterization of mitogen-induced autorosette-forming cells: correlation with T-cell subsets and with lymphocyte proliferative responses to mitogens.
    Ichikawa Y; Lavastida MT; Gonzalez EB; Daniels JC
    Cell Immunol; 1983 Mar; 76(2):351-60. PubMed ID: 6601521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
    Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
    Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity of mitogen-induced autorosette-forming cells to interleukin 2 (T-cell growth factor).
    Ichikawa Y; Daniels JC
    Cell Immunol; 1983 Feb; 76(1):105-12. PubMed ID: 6600976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of non-Hodgkin's lymphomas using multiple cell markers. Immunologic, morphologic, and cytochemical studies of 72 cases.
    Pinkus GS; Said JW
    Am J Pathol; 1979 Feb; 94(2):349-80. PubMed ID: 311589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Morphologic and immunologic criteria for the diagnosis of non-Hodgkin's lymphoma of low-grade malignancy].
    Odermatt BF; Maurer R; Rüttner JR
    Schweiz Rundsch Med Prax; 1986 Apr; 75(15):401-7. PubMed ID: 3485809
    [No Abstract]   [Full Text] [Related]  

  • 10. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between benign and malignant human lymph nodes by means of immunologic markers.
    Brubaker DB; Whiteside TL
    Cancer; 1979 Apr; 43(4):1165-76. PubMed ID: 376086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of immunologic markers with histologic features of human non-Hodgkin's lymphomas.
    Brubaker DB; Whiteside TL; Hartsock RJ
    Am J Clin Pathol; 1979 Jun; 71(6):651-64. PubMed ID: 377943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological classification of lymphoma and lymphocytic leukemias (author's transl)].
    Derre M; Tubiana N; Carcassonne Y
    Sem Hop; 1980 Dec 18-25; 56(47-68):1999-2003. PubMed ID: 6256913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterization of non-Hodgkin's lymphoma: enrichment of neoplastic cells from lymphoid tissues and blood.
    Bom-Van Noorloos AA; Van Beek AA; Ubels-Postma J; Zeijlemaker WP; Van Heerde P; Von Dem Borne AE; Cleton FJ; Melief CJ
    Cancer; 1982 Apr; 49(8):1605-12. PubMed ID: 6978173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface marker studies in chronic lymphocytic leukaemia and non-Hodgkin's lymphoma.
    Leong AS; Forbes IJ; Cowled PA; Sage RE; Black RB; Dale B; Zalewski PD
    Pathology; 1979 Jul; 11(3):461-71. PubMed ID: 392424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of autorosette forming cells in antibody synthesis in vitro: suppressive activity of ARFC in humoral immune response.
    Khansari N; Petrini M; Ambrogi F; Goldschmidt-Clermont P; Fudenberg HH
    Immunobiology; 1984 Jan; 166(1):1-11. PubMed ID: 6232205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of intracellular and cell surface immunoglobulin in non-Hodgkin's lymphoma.
    Davey FR; Halliday D; Marucci AA; Gottlieb AJ
    Hum Pathol; 1978 May; 9(3):285-94. PubMed ID: 350755
    [No Abstract]   [Full Text] [Related]  

  • 19. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
    Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
    Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma.
    Kinoshita K; Kamihira S; Ikeda S; Yamada Y; Muta T; Kitamura T; Ichimaru M; Matsuo T
    Cancer; 1982 Oct; 50(8):1554-62. PubMed ID: 6981451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.